RBMMMDA: predicting multiple types of disease-microRNA associations

• Published in: Scientific reports Vol. 5; no. 1; p. 13877
• Main Authors: Chen, Xing, Clarence Yan, Chenggang, Zhang, Xiaotian, Li, Zhaohui, Deng, Lixi, Zhang, Yongdong, Dai, Qionghai
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 08.09.2015; Nature Publishing Group
• Subjects: 631/114/2397; 631/337/384/331; 631/553/2695; Algorithms; Alzheimer's disease; Biomarkers; Breast cancer; Cell cycle; Computational Biology - methods; Computer applications; Epigenetics; Gene expression; Genetic Association Studies - methods; Genetic Predisposition to Disease; Humanities and Social Sciences; Humans; Lung cancer; Medical prognosis; Metastasis; MicroRNAs; MicroRNAs - genetics; miRNA; multidisciplinary; Proteins; Reproducibility of Results; ROC Curve; Science; Software
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/srep13877

Accumulating evidences have shown that plenty of miRNAs play fundamental and important roles in various biological processes and the deregulations of miRNAs are associated with a broad range of human diseases. However, the mechanisms underlying the dysregulations of miRNAs still have not been fully understood yet. All the previous computational approaches can only predict binary associations between diseases and miRNAs. Predicting multiple types of disease-miRNA associations can further broaden our understanding about the molecular basis of diseases in the level of miRNAs. In this study, the model of Restricted Boltzmann machine for multiple types of miRNA-disease association prediction (RBMMMDA) was developed to predict four different types of miRNA-disease associations. Based on this model, we could obtain not only new miRNA-disease associations, but also corresponding association types. To our knowledge, RBMMMDA is the first model which could computationally infer association types of miRNA-disease pairs. Leave-one-out cross validation was implemented for RBMMMDA and the AUC of 0.8606 demonstrated the reliable and effective performance of RBMMMDA. In the case studies about lung cancer, breast cancer and global prediction for all the diseases simultaneously, 50, 42 and 45 out of top 100 predicted miRNA-disease association types were confirmed by recent biological experimental literatures, respectively.